A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Nobel laureate Carolyn Bertozzi to rejoin Lilly board
Carolyn Bertozzi is rejoining the board of Eli Lilly on Dec. 8, the pharma giant disclosed in a Friday evening SEC filing. The 2022 Nobel laureate, who has ...
Eli Lilly becomes first drugmaker to hit $1 trillion in market value
The pharmaceutical company’s success developing medicines for obesity has swelled its worth to levels associated with tech titans like Apple and Google and dwarfed that...
Novo, Lilly begin to sell obesity medications directly to employers
Building on the growing success of offering cheaper cash-pay prices to consumers for their GLP-1 weight loss drugs, Novo Nordisk and Eli Lilly are setting up programs t...
Lilly becomes first $1 trillion pharma company
Eli Lilly's market valuation briefly reached more than a trillion dollars on Friday, making it the first-ever drugmaker to reach that benchmark. It hit the 13-digit val...
Eli Lilly becomes first drugmaker to hit $1 trillion in market value
The pharmaceutical company’s success developing medicines for obesity has swelled its worth to levels associated with tech titans like Apple and Google and dwarfed that...
Bringing Industry-Relevant Lab Experience to Undergraduate Life Sciences Majors with MyGlo®
When Dr. Rebecca Miles retired from her 25-year career in pharmaceutical research at Eli Lilly, she refocused her passion for science on a new challenge. Having worked...
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page